NAT-LENALIDOMIDE
Identification of Nat-Lenalidomide
| No description |
Google image searchProduct monograph
Active ingredient
lenalidomide, 5 MG
DIN: 02493845
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 01-SEP-2021
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AX — Other immunosuppressants (ATC, ATC/DDD)
- L04AX04 — LENALIDOMIDE (ATC/DDD)
Reference brand drug: Revlimid
